Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Parallel Randomised Phase II Trial of CHOP Chemotherapy With or Without Bortezomib in Relapsed Mantle Cell Lymphoma

NCT00513955 is registered in ClinicalTrials.gov with University Hospital Plymouth NHS Trust as lead sponsor.

NCT NCT00513955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00513955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Parallel Randomised Phase II Trial of CHOP Chemotherapy With or Without Bortezomib in Relapsed Mantle Cell Lymphoma
Lead sponsor
University Hospital Plymouth NHS Trust
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2006
Completion date
October 31, 2014
Enrollment
50 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma